| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.08 | 0.2 |